Kevinkd123-123_123 · Newsroom
The STING pathway targeting technologies market
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy.
March 15, 2021
The STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%, till 2030
Roots Analysis has done a detailed study on STING Pathway Targeting Therapeutics and Technologies, 2020-2030.” covering key aspects of the industry and identifying future growth opportunities.
March 15, 2021
Many small / macro molecule-based STING pathway modulators are currently being evaluated
Many small / macro molecule-based STING pathway modulators are currently being evaluated as monotherapies as well as in combination with other drugs, claims Roots Analysis
March 15, 2021
The subcutaneous biologic drugs and affiliated technologies market
Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer.
March 15, 2021
The subcutaneous biologic drugs and affiliated technologies market
Roots Analysis has done a detailed report on Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030 covering key aspects of the industry and identifying future growth opportunities
March 15, 2021
More than 100 subcutaneous biologics have been approved and over 350 such drug candidates are being evaluated
Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration.
March 15, 2021
The cell and advanced therapies supply chain management market
Roots Analysis has done a detailed study on Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions
March 9, 2021
The “Cell and Advanced Therapies Supply Chain Management Market, 2020-2030”
To order this 510+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapies-supply-chain/260.html
March 9, 2021
Cancer biomarkers market for TMB, MSI / MMR and TILs
Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions
March 8, 2021
Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow at an annualized rate of ~18%, till 2030
Roots Analysis has done a detailed study on Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030, covering key aspects of the industry and identifying key future growth opportunities.
March 8, 2021
The Companion Diagnostics Development Services Market
In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertiseMarch 8, 2021
The Companion Diagnostics Development Services Market is projected to grow at an annualized rate of ~5%, till 2030
Roots Analysis has done a detailed report on Companion Diagnostics Development Services Market covering key aspects of the industry and identifying future growth opportunitiesMarch 8, 2021
The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030
Bispecific antibody therapeutics represent a transformative approach to modern treatment; over the years, this upcoming class of ‘two-target’ artificially engineered drugs have generated significant enthusiasm within the medical science community
March 5, 2021
The bispecific antibody therapeutics market is projected to grow at an annualized rate of ~16%, in the span of 2019 to 2030
Roots Analysis has done a detailed study on Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
March 5, 2021
The biopharmaceutical contract manufacturing market
Roots Analysis has done a detailed study on Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
March 4, 2021
The biopharmaceutical contract manufacturing market
Outsourcing has become a popular trend among biopharmaceutical developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages
March 4, 2021
Over 115 companies located in various regions across the globe claim to provide contract fill / finish services
Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment
March 4, 2021
The contract fill / finish services market for biologics market
Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.March 4, 2021
Over 115 companies located in various regions across the globe claim to provide contract fill / finish services
Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations
March 4, 2021
The opportunity for AR / VR based digital marketing service
Given the present scenario, many stakeholders are adopting such advanced marketing strategies to drive better consumer engagement through the use of immersive and interactive technologies
March 3, 2021
The market opportunity for AR / VR based healthcare digital marketing service
Over time, many pharma companies have begun incorporating augmented reality (AR) and virtual reality (VR) features, in order to offer an experiential and interactive dimension to their educational / marketing content
March 3, 2021
The AR / VR based digital marketing service providers in healthcare sector
Roots Analysis has done a detailed study on “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
March 3, 2021
The antibody drug conjugates market is projected to grow at an annualized rate of over 20%
Roots Analysis has done a detailed report on Antibody Drug Conjugates Market, covering various important aspects of the industry and identifying key future growth opportunities.
March 3, 2021
The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030- Roots Analysis
Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community
March 3, 2021
The ‘Antibody Drug Conjugates Market (5th Edition), 2019-2030’
The ‘Antibody Drug Conjugates Market (5th Edition), 2019-2030’ report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade.
March 3, 2021
The global digital therapeutics market is projected to be worth over USD 8.8 billion by 2030
Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions.
February 26, 2021
The global digital therapeutics market is projected to be worth over USD 8.86 billion by 2030
Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions
February 26, 2021
endocannabinoid system targeted therapeutics market is projected to be over USD 5 billion by 2030
So far, more than 100 different cannabinoids have been identified, and there is a growing body of evidence supporting the clinical benefits of this class of compounds in treating the symptoms of a wide variety of chronic health conditions
February 25, 2021
contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030
Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world
February 24, 2021
The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion
Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery
February 23, 2021
The global digital biomarkers market is projected to be worth over USD 22 billion by 2030
Advances in information technology and biomedical science have enabled the development of digital solutions for biomarkers, which, owing to the myriad of pertinent applications, are being increasingly adopted in modern healthcare practices
February 23, 2021
global digital biomarkers market is projected to be worth over USD 22 billion by 2030
Advances in information technology and biomedical science have enabled the development of digital solutions for biomarkers, which, owing to the myriad of pertinent applications, are being increasingly adopted in modern healthcare practices
February 23, 2021
The antibody discovery services market is estimated to be worth around USD 6.5 billion by 2030
Antibody therapeutics have made it possible to address the hard to target hotspots, rendering the domain of antibody discovery an emerging sector in the pharmaceutical industry
February 22, 2021
85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications
The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare.
February 22, 2021
The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030
Roots Analysis has done a detailed study on Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms
February 22, 2021
over 100 service providers across the globe have capabilities to handle high energy / hazardous chemistry conditions
Various service providers claim to possess the required equipment for API synthesis under hazardous (high / low temperature and high / low pressure) conditions. Over time, the shift to high energy synthesis chemistries
February 18, 2021
High Energy / Hazardous Chemistry-based API manufacturing services market
Although hazardous reaction chemistries are not used during early drug development stages owing to the associated risks, they offer a wide range of benefits over traditional approaches.February 18, 2021
Growing at an annualized rate of 12%, the HPAPI and cytotoxic drugs
Manufacturing highly potent drug products is technically and financially demanding; as a result, drug manufacturers are becoming increasingly reliant on contract service providers
February 18, 2021
120 companies across the globe claim to possess the required expertise and infrastructure to offer contract manufacturing services
Development initiatives of HPAPIs and cytotoxic drugs are generally very demanding, both in terms of experience and capital investment.February 18, 2021
115 companies located in various regions across the globe claim to provide contract fill / finish services for various types of biopharmaceutical drug
Despite the fact that biopharmaceuticals offer significant profit margins, innovator companies are plagued by high costs of development, complex production protocols and special procedures and equipment for fill / finish operations.
February 17, 2021
The contract fill / finish services market for biologics market is projected to grow at an annualized rate of ~10%, till 2030
Roots Analysis has done a detailed study on Biologics Fill / Finish Services Market, 2019-2030, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
February 17, 2021
The contract fill / finish services market for biologics is anticipated to be worth USD 4.2 billion by 2030, predicts Roots Analysis
A steadily growing demand for biologic fill / finish services has generated a range of new opportunities for contract service providers; stakeholders have invested heavily to ensure product integrity and safety
February 17, 2021
The antibody contract manufacturing market is projected to reach USD 17 billion by 2030, growing at an annualized rate of 12%, claims Roots Analysis
With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone
February 16, 2021
The diabetes monitoring devices market is estimated to be worth USD 34 billion in 2030, predicts Roots Analysis
The diabetes monitoring devices market is anticipated to witness steady growth, largely driven by the increasing diabetic patient population and the introduction of advanced and cost-effective solutions, in the coming years
February 16, 2021
The diabetes monitoring devices market is projected to grow at a CAGR of 8%, claims Roots Analysis
The anticipated growth in the global diabetic patient population is likely to translate into significant rise in demand for advanced, cost-effective and more patient friendly solutions for disease monitoring
February 16, 2021
Presently, over 240 novel, patient friendly diabetes monitoring devices are available / being developed
Over time, a number of companies have developed advanced variants of the conventional blood glucose monitoring devices, which are portable, and minimally / non-invasive.February 16, 2021
The “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019-2030”
A comparative analysis of the needs of different stakeholders (drug developers, diagnostic developers
January 29, 2021
Presently, close to 50 companies are offering a variety of analytical testing solutions for the assessment of novel cancer biomarkers
Several companies have already developed / are developing analytical tests for novel cancer biomarkers (TMB, MSI / MMR and TILs), intended to assist physicians in making personalized treatment decisions.
January 29, 2021
Cancer biomarkers market for TMB, MSI / MMR and TILs is projected to grow at an annualized rate of ~18%, till 2030
The projected future opportunity is expected to be distributed across different application areas, types of analytical techniques used and various global regions
January 29, 2021
Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis
A discussion on various steps involved in development operations of companion diagnostics
January 29, 2021